Research Articles

Peer-reviewed studies distilled into actionable summaries. Updated daily.

Total: 49,449 articles • Showing 2 of 49,449
pubmed

Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.

Fombellida-Lopez C; Valaitienė A; Winchester L; Maes N; Dellot P; Vanwinge C; Ladang A; Cavalier E; Susin F; Vaira D; Hayette MP; Reenaers C; Moutschen M; Fletcher CV; Pasternak AO; Darcis G

Researchers explored whether increasing the medication dose for treating HIV could stop the virus completely. They found that doubling the dose of one drug helped reduce some signs of the virus and immune activation in the body but didn't change inflammation levels. This suggests the regular treatment might not work perfectly for everyone.

View Details
pubmed

The IBEX knowledge-base a community resource enabling adoption and development of immunofluorescence imaging methods.

Yaniv Z; Anidi IU; Arakkal L; Arroyo-Mejías AJ; Beuschel RT; Börner K; Chu CJ; Clark BH; Clatworthy MR; Colautti J; Coscia F; Croteau J; Denha S; Dever R; Dutra WO; Fritzsche S; Fullam S; Gerner MY; Gola A; Gollob KJ; Hernandez JM; Hor JL; Ichise H; Jing Z; Jonigk D; Kandov E; Kastenmüller W; Koenig JFE; Kothurkar A; Kortekaas RK; Kreins AY; Lamborn IT; Lin Y; Luciano Pereira Morais K; Lunich A; Luz JCS; MacDonald RB; Makranz C; Maltez VI; McDonough JE; Moriarty RV; Ocampo-Godinez JM; Murakami Olyntho V; Oxenius A; Padhan K; Remmert K; Richoz N; Schrom EC; Shang W; Shi L; Shih RM; Speranza E; Stierli S; Teichmann SA; Verse TZ; Vierhout M; Wachter BT; Wade-Vallance AK; Williams M; Zangger N; Germain RN; Radtke AJ

The IBEX Knowledge-Base is a tool that helps scientists share and learn about special imaging techniques used in research. It provides a place where researchers can find useful data, share their own findings, and talk with each other to make scientific discoveries faster and more reliable.

View Details
🔒

Unlock 49,447+ More Articles

Upgrade to the Weekly Digest and get unlimited access to all research articles, plain-language takeaways, and our AI research assistant.

or

Get the science breakthroughs you need—
every Tuesday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

Want to see what you'll get?

View Sample: How Do We Know What We Know?

🔒 No spam. 1-click opt-out. Privacy-first.